Action and the actionability in exome variation

Circulation: Cardiovascular Genetics

Volumn 5, Issue 6, 2012, Pages 597-598

  MacRae, Calum A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

BIOASSAY; CHANGE MANAGEMENT; EDITORIAL; EXOME; GENE FREQUENCY; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROCESSING; RNA TRANSLATION;

CARDIOMYOPATHIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; SARCOMERES;

EID: 84873935699     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.112.965152     Document Type: Editorial

References (11)

1. Borecki IB, Province MA. Genetic and genomic discovery using family studies. Circulation. 2008;118:1057-1063.
2. Casimiro MC, Knollmann BC, Yamoah EN, Nie L, Vary JC Jr, Sirenko SG, et al. Targeted point mutagenesis of mouse Kcnq1: Phenotypic analy-sis of mice with point mutations that cause Romano-Ward syndrome in humans. Genomics. 2004;84:555-564.
3. Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac remod-eling. Annu Rev Genomics Hum Genet. 2005;6:185-216.
4. Pan S, Caleshu CA, Dunn KE, Foti MJ, Moran MK, Soyinka O, et al. Cardiac structural and sarcomeric genes associated with cardiomyopathy exhibit marked intolerance of genetic variation. Circ Cardiovasc Genet. 2012;5:602-610.
5. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, et al.; 1000 Genomes Project Consortium. A systematic survey of loss-of-function variants in human protein-coding genes. Science. 2012;335:823-828.
6. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsa-ker RE, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65.
7. Ashrafian H, McKenna WJ, Watkins H. Disease pathways and novel thera-peutic targets in hypertrophic cardiomyopathy. Circ Res. 2011;109:86-96.
8. MacRae CA. Closer look at genetic testing in long-QT syndrome: Will DNA diagnostics ever be enough? Circulation. 2009;120:1745-1748.
9. Hartman JLT, Garvik B, Hartwell L. Principles for the buffering of genetic variation. Science. 2001;291:1001-1004.
10. Bartoszewski RA, Jablonsky M, Bartoszewska S, Stevenson L, Dai Q, Kappes J, et al. A synonymous single nucleotide polymorphism in Del-taF508 CFTR alters the secondary structure of the mRNA and the expres-sion of the mutant protein. J Biol Chem. 2010;285:28741-28748.
11. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 2011;146:353-358.